New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like Excess weight gain in first trimester associated with fetal fat accumulation January 18, 2025 Discrimination may accelerate aging May 9, 2024 Visualising multiple sclerosis with a new MRI procedure February 9, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.